Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2001

Syringe, pen, inhaler - the evolution of insulin therapy.

Igor Alexander Harsch, Eckhart Georg Hahn, Peter Christopher Konturek

Med Sci Monit 2001; 7(4): RA833-836 :: ID: 421063


The therapy with inhalable insulin can be expected to change the presentconcepts and the market of subcutaneous insulin dramatically within the next years. Several companiesare currently developing formulations of inhalable insulin. In the most advanced concept, insulin isdelivered as a dry-powder insulin formulation via a special aerosol device system. The phase III studiesevaluating the efficiency of the inhaled insulin are already on their way. The recent phase II studieshave shown, that the lung is capable of absorbing new insulin formulation in a dose-dependent and reproduciblemanner. However, a relatively small number of diabetic patients have been included in these studies,yet. The therapeutic efficacy and safety of the inhaled insulin is comparable to that of the usual subcutaneousinsulin treatment regimens. The most important advantage of the new therapy is the enhanced therapeuticcomfort of the patient who does not need to inject insulin for meal time glucose control. Generally,in terms of glycemic control, inhalable insulin offers no advantages in type 1 diabetics in comparisonto an intensified conventional insulin therapy. However, before a large-scale marketing, several openquestions have to be carefully investigated, the most important being the possible long-term effectsof insulin inhalation for the lung, since insulin is known to have growth-promoting properties. Thereis still no available clinical data concerning the efficiency of the inhaled insulin in patients withpulmonary diseases which may cause problems in absorption of inhaled insulin due to the smaller cumulativealveolar surface. In smokers without pulmonary disease seems the inhaled insulin to act stronger andfaster. Since therapy with inhalable insulin requires larger doses of insulin in comparison to subcutaneousinsulin to achieve the same systemic effect, the costs of this therapy need to be clarified, too.

Keywords: inhaled insulin, lung function, fibrogenesis, Diabetes Mellitus, alveoles

Add Comment 0 Comments


01 February 2024 : Editorial  

Editorial: Global Health Concerns as Vaccine-Preventable Infections Including SARS-CoV-2 (JN.1), Influenza, Respiratory Syncytial Virus (RSV), and Measles Continue to Rise

Dinah V. Parums

DOI: 10.12659/MSM.943911

Med Sci Monit 2024; 30:e943911


In Press

28 Dec 2023 : Clinical Research  

Prognostic Assessment of Colorectal Cancer Patients after Laparoscopic Surgery: A Comprehensive Evaluation ...

Med Sci Monit In Press; DOI: 10.12659/MSM.942658  


05 Jan 2024 : Clinical Research  

Effectiveness of Glutamine Oral Care in Reducing Oral Mucositis and Improving Oral Health After Neurosurger...

Med Sci Monit In Press; DOI: 10.12659/MSM.942585  

02 Jan 2024 : Clinical Research  

Urinary Concentration of Renal Biomarkers in Healthy Term Neonates: Gender Differences in GST-pi Excretion

Med Sci Monit In Press; DOI: 10.12659/MSM.942819  

29 Dec 2023 : Clinical Research  

Performance of Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) in Chinese Population with Prima...

Med Sci Monit In Press; DOI: 10.12659/MSM.942747  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750